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Wednesday, February 11, 2015 573aelectron microscopy (EM) and super-resolution microscopy (gSTED, STORM)
and used optical mapping and computer modeling to investigate the implica-
tions for ephaptic conduction in the heart. gSTED and STORM revealed
Nav1.5 and b1 enrichment within ID regions not containing dense clusters of
Cx43 and N-Cadherin. Notably, both were identified within the perinexus, a mi-
crodomain surrounding Cx43 gap junctions. Overall, 22% of Nav1.5 was
located within perinexal regions while only 2% was within Cx43 clusters.
EM revealed closer membrane apposition at perinexal (<10nm) vs. non-
perinexal intercalated disk sites (>10nm) under control conditions. AIE
increased intermembrane distance at perinexal, but not at non-perinexal sites.
Functionally, this correlated with decreased transverse conduction velocity
(CV-T; 15.250.3 vs. 19.650.1cm/s) and increased anisotropic ratio (AR;
3.050.2 vs. 2.850.1) relative to control, in perfused guinea pig ventricles.
Next, we investigated AIE effects on Nav1.5 function in conduction. Nav1.5
blockade (0.5 mM flecainide) by itself decreased CV (18%) without changing
AR. However, Nav1.5 inhibition during AIE preferentially decreased CV-T
(13.050.6cm/s), increased AR (3.350.2) and increased spontaneous arrhyth-
mias (7/9 vs. 4/11) compared to AIE alone. Notably, only a computer model
including ephaptic coupling and the ID localization of Nav1.5 could recapitu-
late these results. In summary, sodium channel complexes localized to ID mi-
crodomains such as the perinexus may enable ephaptic conduction in the heart.
Further, Nav1.5 functional availability and perinexal membrane spacing
emerge as novel determinants of anisotropic conduction.
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Sodium channel mutations near the IQ and EFL motifs in the carboxyterminal
(CT) domain have been linked to long QT (LQTS) and Brugada syndromes
(BrS). IQ-calmodulin (CaM) interaction is important for regulation of cardiac
Na channels. The aim of this study was to assess the role of Naþ–Ca2þ/CaM
signaling via IQ motif of the Naþ channels in development and maturation
of intercalated disc (ID). We studied transgenic mice with alanines knocked
into IQ positions in the Nav1.5 CT. The homozygous mice are embryonic lethal
and heterozygous mice (IQ/AAþ/ mice), develop cardiomyopathy (DCM).
We measured the signal and distribution of Nav1.5, syntrophin, Cx43 and rya-
nodine in 3 and 9 month old IQ/AAþ/ mice. Results were compared to those
obtained from age matched wild type mice. By immunohistochemistry we
show that Nav1.5 protein in 9 month-old IQ/AA
þ/ mice is significantly
reduced at the ID. Syntrophin that traffics Na channels to the membrane, is
not altered. Cx43 which is co-located with Nav1.5 at the ID, is significantly
reduced. The expression of these proteins were not altered in 3 month-old
IQ/AAþ/ mice. We also assessed the implication of IQ domain on the local-
ization of Ca2þ handling protein such as ryanodine receptor and found that it
was significantly altered in 9 month-old IQ/AAþ/ mice. The data suggest
that enhanced late INa,L in IQ/AA
þ/ mice contributes to DCM via remodeling
of electrical and junctional proteins and demonstrate a dynamic interplay of
Naþ–Ca2þ/CaM signaling via IQ motif of the Naþ channels in ID development
and maturation. Our study highlights the importance of Ca2þ/CaM-mediated
regulation of Naþ channels in DCM and arrhythmia.
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Long QT type 3 (LQT3) is caused by mutations that cause an increase in the
cardiac sodium current during late phases of the cardiac action potential. For
a number of LQT3 mutants this is caused by a failure to inactivate fully, and
a consequent increase in late sodium current. For several mutations, shifts in
voltage dependence of activation and inactivation cause increased sodium
channel contribution to more depolarized voltages, an effect referred as in-
crease in window current. The goal of this study was to perform a study in a
large number of LQT3 associated mutations and compare the biophysical effect
of the mutation to cardiac risk in LQT3 patients and response to treatment. We
measured the function of eight common mutations associated with LQT3 with
different mechanism underlying channel dysfunction. We compared the func-
tional effects of the channel with the clinical course of these patients andobserved that for the two mutations tested with increased sustained current
but without increase in current availability (window current), D1784K and
D1790G, the patients had significant lower risk of cardiac events, suggesting
an increase in current availability may be associated with increased risk for
these patients. In addition, we measured mutation specific effects of ranolazine
for these mutants. For all mutants tested, ranolazine preferentially blocked late
sodium currents. Ranolazine shifts steady-state availability of the inactivation
was dependent on the specific mutant tested. Our results suggest that ranolazine
may have a mutation dependent effect. Mutations dysfunction may affect drug
binding and drug actions in the channel and may alter treatment effectiveness in
patients.
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Pyrethroid insecticides target voltage-gated sodium channels. Emerging
mosquito resistance to widely used pyrethroids demands development of
new insecticides. Earlier the X-ray structure of the open Kv1.2 channel and
mutagenesis data were used to build two homology models of insect sodium
channels with pyrethroid receptors PyR1 (O’Reilly et al., 2006) and PyR2
(Du et al., 2013) located, respectively, in the II/III and I/II domain interfaces.
The models differ in the number of contributing transmembrane helices,
orientation of the bound pyrethroid molecules, and the depth of their penetra-
tion in respective domain interfaces. Here we employed our PyR2 model to
elaborate an analogous PyR1 model. Computational docking yielded a revised
PyR1 model with deltamethrin bound between the linker helix IIS4-S5 and
transmembrane helices IIS5, IIS6 and IIIS6 with its dibromoethenyl and
diphenylether moieties oriented, respectively, in the intra- and extracellular
directions. Comparison of the PyR2 and revised PyR1 models predicted
new deltamethrin-channel contacts. Model-driven mutagenesis followed by
electrophysiological measurements unveiled two new pyrethroid-sensing res-
idues in PyR1 and four such residues in PyR2. Taken together, the new and
previously published data support the following conclusions. (i) PyR1 is
formed by helices IIS4-S5, IIS5, IIS6, and IIIS6. PyR2 is formed by helices
IS4-S5, IS5, IS6, and IIS6. (ii) Helix IIS6 contains four residues that
contribute to PyR1 and four residues that contribute to PyR2. (iii) Seven pairs
of pyrethroid-sensing residues are located in analogous positions of domain
interfaces I/II and II/III indicating rotational symmetry of the two pyrethroid
receptor sites. (iv) Pyrethroids bind to both sites in similar orientations,
deeply penetrating in the respective domain interfaces. Our study elaborates
the dual pyrethroid-receptor sites model and provides a structural background
for rational development of new pyrethroid insecticides. Supported by NIH
and NSERC.
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Voltage-gated sodium channel (Nav) inhibitors are used clinically as analgesics
and local anesthetics. However, the absence of Nav channel isoform selectivity
of current treatment options can result in adverse cardiac and CNS side effects,
limiting their therapeutic utility. Human hereditary gain- or loss-of-pain
disorders have demonstrated an essential role of Nav1.7 sodium channels in
the sensation of pain, thus making this channel an attractive target for new
pain therapies. We have identified a novel, human Nav1.7 selective inhibitor
(PF-05089771, IC50¼ 11 nM) that preferentially interacts with, and stabilizes,
inactivated conformation(s) of the channel via an interaction with the voltage-
sensor domain (VSD) of Domain 4. The current study demonstrates that
PF-05089771 exhibits concentration-dependent slowly developing inhibition
(tau ¼ 209 sec and 33 sec, at 100 nM and 1 mM, respectively), and a similarly
slow recovery from block upon washout (tau ~7 min). PF-05089771 exhibits
minimal use-dependent inhibition until concentrations exceed 10-fold the
IC50, which is consistent with the observed slow onset of block and/or a low
affinity for resting or fast-inactivated channel conformations. To evaluate
this further, we employed whole cell patch clamp protocols to separate
channels into predominantly fast- or slow-inactivated Nav populations. Inhi-
bition by PF-05089771 develops with similar rates using protocols that biases
for either fast- or slow-inactivated states, suggesting that preference for a
particular inactivated state (fast, intermediate or slow) appears less critical
than the relative time that the channel is in an inactivated state during
